4.5 Article

A coding variant in CR1 interacts with APOE-?4 to influence cognitive decline

Journal

HUMAN MOLECULAR GENETICS
Volume 21, Issue 10, Pages 2377-2388

Publisher

OXFORD UNIV PRESS
DOI: 10.1093/hmg/dds054

Keywords

-

Funding

  1. National Institutes of Health (NIH) [R01 AG30146, R01 AG179917, R01 AG15819, K08 AG034290, P30 AG10161, R01 AG11101, R01NS059873, P50 AG16573, R01 AG034504, K01AG024079, U01 AG024904, P30 AG010129, K01 AG030514]
  2. Illinois Department of Public Health
  3. Burroughs Wellcome Fund
  4. Beth Israel Deaconess Medical Center-Harvard/MIT Health Sciences and Technology
  5. Pfizer, Inc.
  6. Merck Co.
  7. Arizona Alzheimer's Disease Center [P30 AG19610, RO1 AG023193]
  8. Mayo Clinic Alzheimer's Disease Center [P50 AG16574]
  9. Kronos Life Sciences Laboratories, the National Alzheimer's Coordinating Center [U01 AG016976]
  10. NIH Neuroscience Blueprint [U24NS051872]
  11. ENDGAME Consortium [UO1HL084744]
  12. state of Arizona
  13. National Institute of Biomedical Imaging and Bioengineering
  14. Northern California Institute for Research and Education
  15. Dana Foundation
  16. MRC [G0701075] Funding Source: UKRI
  17. Alzheimers Research UK [ART-PG2010-1, ART-PPG2011A-14] Funding Source: researchfish
  18. Medical Research Council [G0701075] Funding Source: researchfish

Ask authors/readers for more resources

Complement receptor 1 (CR1) is an Alzheimers disease (AD) susceptibility locus that also influences AD-related traits such as episodic memory decline and neuritic amyloid plaque deposition. We implemented a functional fine-mapping approach, leveraging intermediate phenotypes to identify functional variant(s) within the CR1 locus. Using 1709 subjects (697 deceased) from the Religious Orders Study and the Rush Memory and Aging Project, we tested 41 single-nucleotide polymorphisms (SNPs) within the linkage disequilibrium block containing the published CR1 AD SNP (rs6656401) for associations with episodic memory decline, and then examined the functional consequences of the top result. We report that a coding variant in the LHR-D (long homologous repeat D) region of the CR1 gene, rs4844609 (Ser1610Thr, minor allele frequency 0.02), is associated with episodic memory decline and accounts for the known effect of the index SNP rs6656401 (D 1, r(2) 0.084) on this trait. Further, we demonstrate that the coding variants effect is largely dependent on an interaction with APOE-?4 and mediated by an increased burden of AD-related neuropathology. Finally, in our data, this coding variant is also associated with AD susceptibility (joint odds ratio 1.4). Taken together, our analyses identify a CR1 coding variant that influences episodic memory decline; it is a variant known to alter the conformation of CR1 and points to LHR-D as the functional domain within the CR1 protein that mediates the effect on memory decline. We thus implicate C1q and MBL, which bind to LHR-D, as likely targets of the variants effect and suggest that CR1 may be an important intermediate in the clearance of A42 particles by C1q.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available